Long term efficacy and safety of patients with Ankylosing spondylitis treated with etanercept for 5 years: Analysis of different types of response

被引：0
|
作者：
Baraliakos, Xenofon [1 ]
Listing, J. [2 ]
Fritz, C. [2 ]
Song, In-Ho [3 ]
Haibel, H. [3 ]
Heldmann, F. [1 ]
Rudwaleit, M. [3 ]
Sieper, J. [3 ]
Braun, Juergen [1 ]
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Charite, Berlin, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S357 / S357
页数：1
相关论文
共 50 条
  • [1] Long term efficacy and safety of patients with ankylosing spondylitis treated with etanercept for years - Analysis of different types of response
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Song, I. H.
    Haibel, H.
    Heldmann, F.
    Brandt, J.
    Rudwaleit, M.
    Sieper, J.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 745 - 746
  • [2] Long term efficacy and safety results and patient reported outcomes in patients with ankylosing spondylitis treated with etanercept for 4 years
    Dijkmans, B. A. C.
    Sieper, J.
    van der Linden, S.
    Martin-Mola, E.
    Leirisalo-Repo, M.
    Singh, A.
    Freundlich, B.
    Koenig, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 395 - 395
  • [3] Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
    Miguel Senabre-Gallego, Jose
    Santos-Ramirez, Carlos
    Santos-Soler, Gregorio
    Salas-Heredia, Esteban
    Sanchez-Barrioluengo, Mabel
    Barber, Xavier
    Rosas, Jose
    PATIENT PREFERENCE AND ADHERENCE, 2013, 7 : 961 - 972
  • [4] LONG-TERM OUTCOME OF PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS WITH ETANERCEPT - SUSTAINED EFFICACY AND SAFETY AFTER 7 YEARS
    Baraliakos, X.
    Haibel, H.
    Fritz, C.
    Listing, J.
    Heldmann, F.
    Braun, J.
    Sieper, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 638 - 638
  • [5] Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
    Brandt, J
    Listing, J
    Haibel, H
    Sörensen, H
    Schwebig, A
    Rudwaleit, M
    Sieper, J
    Braun, J
    RHEUMATOLOGY, 2005, 44 (03) : 342 - 348
  • [6] Long-term efficacy, including halting of radiographicprogression, and safety of etanercept in patients with ankylosing spondylitis
    Dijkmans, B.
    Sridharan, S.
    Fatenejad, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 187 - 187
  • [7] Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years
    Baraliakos, Xenofon
    Haibel, Hildrun
    Fritz, Claudia
    Listing, Joachim
    Heldmann, Frank
    Braun, Juergen
    Sieper, Joachim
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (03)
  • [8] Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years
    Xenofon Baraliakos
    Hildrun Haibel
    Claudia Fritz
    Joachim Listing
    Frank Heldmann
    Juergen Braun
    Joachim Sieper
    Arthritis Research & Therapy, 15
  • [9] Long term efficacy and safety of etanercept in patients with ankylosing spondylitis: 148 to 160 week analysis from an ongoing trial
    Sieper, J.
    Dijkmans, B. A. C.
    Van der Linden, S.
    Mola, E. Martin
    Sibilia, J.
    Leirisalo-Repo, M.
    Nab, H. W.
    Chang, D.
    Freundlich, B.
    MacPeeke, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 437 - 438
  • [10] Sustained efficacy and safety of patients with ankylosing spondylitis treated with etanercept: Outcomes at 148-160 weeks of long term therapy.
    Sieper, Joachim
    Dijkmans, Benjamin A. C.
    van der Linden, Sjef
    Mola, Emilio Martin
    Sibilia, Jean
    Leirisalo-Repo, Majatta
    Nab, Henk W.
    Chang, David
    Freundlich, Bruce
    MacPeek, David
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S473 - S473
12345